Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoran Dai

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|March 16, 2023
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou, Haoran Dai, Hanxue Jiang, et al.
Frontiers in Pharmacology|October 10, 2022
MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou, Haoran Dai, Hanxue Jiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 4, 2026
Macrophage extracellular traps in autoimmunity: In vivo definition, pathogenic circuits, and therapeutic targetingMengchao Liu, Mingzhe Wang, Haoran Dai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2026
Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583]Qihan Zhao, Haoran Dai, Hanxue Jiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2024
Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damageQihan Zhao, Haoran Dai, Hanxue Jiang, et al.
Frontiers in Immunology|August 27, 2019
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its RoleWenbin Liu, Chang Gao, Haoran Dai, et al.
Frontiers in Immunology|June 7, 2021
Helper T Cells in Idiopathic Membranous NephropathyQihan Zhao, Haoran Dai, Xianli Liu, et al.
Renal Failure|March 14, 2024
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trialNaiqian Zhang, Hanxue Jiang, Haoran Dai, et al.
Journal of Immunology Research|January 11, 2021
The Potential Role of Regulatory B Cells in Idiopathic Membranous NephropathyZhaocheng Dong, Zhiyuan Liu, Haoran Dai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 23, 2020
Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/<i>β</i>-Catenin Signaling Pathway, Resulting in Activation of Podocyte AutophagyHaoran Dai, Fei Liu, Xinping Qiu, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|March 16, 2023
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou, Haoran Dai, Hanxue Jiang, et al.
Frontiers in Pharmacology|October 10, 2022
MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou, Haoran Dai, Hanxue Jiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 4, 2026
Macrophage extracellular traps in autoimmunity: In vivo definition, pathogenic circuits, and therapeutic targetingMengchao Liu, Mingzhe Wang, Haoran Dai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2026
Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583]Qihan Zhao, Haoran Dai, Hanxue Jiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 16, 2024
Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damageQihan Zhao, Haoran Dai, Hanxue Jiang, et al.
Frontiers in Immunology|August 27, 2019
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its RoleWenbin Liu, Chang Gao, Haoran Dai, et al.
Frontiers in Immunology|June 7, 2021
Helper T Cells in Idiopathic Membranous NephropathyQihan Zhao, Haoran Dai, Xianli Liu, et al.
Renal Failure|March 14, 2024
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trialNaiqian Zhang, Hanxue Jiang, Haoran Dai, et al.
Journal of Immunology Research|January 11, 2021
The Potential Role of Regulatory B Cells in Idiopathic Membranous NephropathyZhaocheng Dong, Zhiyuan Liu, Haoran Dai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 23, 2020
Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/<i>β</i>-Catenin Signaling Pathway, Resulting in Activation of Podocyte AutophagyHaoran Dai, Fei Liu, Xinping Qiu, et al.
Pageof 6